The effectiveness of a non-pharmacological intervention for weight gain management in severe mental disorders: Results from a national multicentric study;Efetividade de uma intervenção não farmacológica para manejo do ganho de peso em pacientes com transtornos mentais graves: Resultados de um estudo multicêntrico

Revista Brasileira de Psiquiatria

Volumn 33, Issue 2, 2011, Pages 117-121

  Attux, Cecília ^a   Martini, Larissa C ^a   de Araújo, Célia Maria ^a   Roma, Ana Maria ^a   Reis, André F ^a   Bressan, Rodrigo A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; DISEASE SEVERITY; FEMALE; HUMAN; INTERVENTION STUDY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH SERVICE; MENTAL PATIENT; NUTRITION; OPEN STUDY; PATIENT COUNSELING; PHYSICAL ACTIVITY; SCHIZOPHRENIA; SELF ESTEEM; WAIST CIRCUMFERENCE; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 80051513037     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462011000200005     Document Type: Article

References (23)

1. Wirshing DA. Schizophrenia and obesity: impact of antipsychotic medications. J Clin Psychiatry. 2004;65(Suppl 18):13-26.
2. Allison DB, Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler L P, Weiden PJ, Cheskin LJ. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry. 1999;60(4):215-220.
3. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA. 2005;293(20):2528-2530.
4. Hoffmann V P, Ahl J, Meyers A, Schuh L, Shults KS, Collins DM, Jensen L. Wellness Intervention for patients with serious and persistent mental illness. J Clin Psychiatry. 2005;66(12):1576-1579.
5. Faulkner G, Soundy AA, Lloyd K. Schizophrenia and weight management: a systematic review of interventions to control weight. Acta Psychiatr Scand. 2003;108(5):324-332.
6. Alvarez-Jiménez M, González-Blanch C, Vázquez-Barquero JL, Pérez-Iglesias R, Martínez-Garcia O, Pérez-Pardal T, Ramírez-Bonilla ML, Crespo-Facorro B. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive frst-episode psychosis patients: a randomized controlled trial. J Clin Psychiatry. 2006;67(8):1253-1260.
7. Attux C, Martini LC, Reis A F, Bressan RA. Intervenções não farmacológicas para manejo do ganho de peso em pacientes com esquizofrenia em uso de antipsicóticos. Arq Bras Endocrinol Metabol. 2009:53(4):391-398.
8. Elkis H, Gama C, Suplicy H, Tambascia M, Bressan RA, Lyra R, Cavalcante S, Minicucci W. Brazilian Consensus on second-generation antipsychotics and metabolic disorders. Rev Bras Psiquiatr. 2008;30(1):77-85.
9. Werneke U, Taylor D, Sanders TA. Options for pharmacological management of obesity in patients treated with atypical antipsychotics. Int Clin Psychopharmacol. 2002;17(4):145-160.
10. Bushe C, Haddad P, Peveler R, Pendlebury J. The role of lifestyle interventions and weight management in schizophrenia. J Psychopharmacol. 2005;19(6 Suppl):28-35.
11. Attux C, Araújo CM, Roma, AM, Mateus M, Campagna L, Canguçu D, Bressan RA. Brazilian Wellness Program: results from first year. Int J Neuropsychopharmacol. 2006;9(Suppl 1):S156.
12. National Advisory Mental Health Council. Health care reform for Americans with severe mental illnesses: report of the National Advisory Mental Health Council. Am J Psychiatry. 1993;150(10):1447-1465.
13. Kinon BJ, Basson BR, Gilmore JA, Tollefson GD. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. J Clin Psychiatry. 2001;62(2):92-100.
14. Evans S, Newton R, Higgins S. Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust N Z J Psychiatry. 2005; 39(6):479-486.
15. Mauri M, Castrogiovanni S, Simoncini M, Iovieno N, Miniati M, Rossi A, Dell'Agnello G, Fagiolini A, Donda P, Cassano GB. Effects of an educational intervention on weight gain in patients treated with antipsychotics. J Clin Psychopharmacol. 2006;26(5):462-466.
16. Littrell KH, Hilligoss NM, Kirshner CD, Petty RG, Johnson CG. The effects of an educational intervention on antipsychotic-induced weight gain. J Nurs Scholarsh. 2003;35(3):237-241.
17. Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry. 2004;65(4):471-477.
18. Kwon JS, Choi JS, Bahk WM, Kim CY, Kim CH, Shin YC, Park BJ, Oh CG. Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: a 12-week randomized controlled clinical trial. J Clin Psychiatry. 2006;67(4):547-553.
19. Williamson D F. Descriptive epidemiology of body weight and weight change in U.S. adults. Ann Intern Med. 1993;119(7 Pt 2):646-649.
20. McKibbin CL, Patterson TL, Norman G, Patrick K, Jin H, Roesch S, Mudaliar S, Barrio C, O'Hanlon K, Griver K, Sirkin A, Jeste D. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: A randomized controlled trial. Schizophr Res. 2006;86(1-3):36-44.
21. Blair SN, Kohl H W, Paffenbarger RS, Clark DG, Cooper KH, Gibbons LW. Physical ftness and all-cause mortality: a prospective study of healthy men and women. JAMA.1989;262(17):2395-2401.
22. Lee CD, Blair SN, Jackson AS. Cardiorespiratory ftness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr. 1999;69(3):373-380.
23. Kolotkin RL, Corey-Lisle PK, Crosby RD, Swanson JM, Tuomari AV, L'Italien GL, Mitchell JE. Impact of obesity on health-related quality of life in schizophrenia and bipolar disorder. Obesity. 2008;16(4):749-754.